A Comparative Study of an Integrated Pharmaceutical Care Plan and a Routine Care in Bronchial Asthma
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of the study is to compare the effect of asthma care by clinical pharmacist intervention versus routine care on asthma control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 24, 2014
CompletedFirst Posted
Study publicly available on registry
January 28, 2014
CompletedJanuary 28, 2014
January 1, 2014
10 months
January 24, 2014
January 24, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Asthma Control Questionnaire
at baseline & after 2 months of therapy
Secondary Outcomes (5)
Forced Expiratory Volume in 1 second (FEV1%)
at baseline & after 2 months of therapy
Rescue Medication SABA (number of puffs used most days)
at baseline & after 2 months of therapy
Inhaled Corticosteroid Use (number of puffs used/day)
at baseline & after 2 months of therapy
Number of courses of systemic steroid used
During 2 months of therapy
Number of ER visits/ Hospitalization
During 2 months of therapy
Other Outcomes (2)
Assessment of Inhalation Technique
at baseline and after 2 months of therapy
Patient Adherence to Therapy
2 months of therapy
Study Arms (2)
Pharmacist-Intervention
EXPERIMENTALRoutine Care
ACTIVE COMPARATORInterventions
Patients received additional education on basic facts about asthma, role of medications, the difference between long-term control medications and quick-relief medications, as well as patient skills in the first visit then reinforcement every two weeks.. The importance of proper inhaler technique, avoidance of asthma triggers and self-monitoring of asthma were also highlighted. Visual aids, physical demonstration as well as written information resources were supplied. Asthma care plans were tailored to patient needs and preferences. Patients were informed how to detect early signs of worsening asthma, when and how to seek medical care as appropriate.
Patients received usual care delivered by physician without pharmacist intervention. Patients were prescribed asthma medication with summarized basic information on asthma and medication use. Follow-up visits were not planned on consistent basis, but rather individually according to the disease status. No asthma action plans were provided.
Eligibility Criteria
You may qualify if:
- patient with clinical diagnosis of bronchial asthma
- responsible for administering their own asthma medications.
You may not qualify if:
- patients who were not responsible for administering their own asthma medications.
- patients with cognitive defects, other pulmonary disease e.g. Chronic Obstructive Pulmonary Disease (COPD), experiencing illness with asthma-like symptoms e.g. Congestive Heart Failure, evidence of fixed airway obstruction
- patients unavailable for 2-month follow-up.
- patients who did not provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University Hospitals
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rana R Farrag
Ahram Canadian University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pharmacist
Study Record Dates
First Submitted
January 24, 2014
First Posted
January 28, 2014
Study Start
March 1, 2012
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
January 28, 2014
Record last verified: 2014-01